Cardiovascular Information Center Archive
Researchers found that 16% of patients received doses inconsistent with US Food and Drug Administration labeling.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Blood pressure levels below the recommended targets lower risk of CVD and all-cause mortality.
Compared with individuals reporting chocolate intake less than once per month, the rate of AF was lower for people consuming chocolate regularly.
The ALLHAT-LLT trial showed that statin therapy for primary cardiovascular prevention may not benefit adults older than 65 years of age.
CVD occurred in 11.8% of participants in the vitamin D group and 11.5% in the placebo group.
The USPSTF recommends that pregnant women receive screening for preeclampsia with blood pressure measurements throughout pregnancy.
Apixaban is associated with a lower risk of gastrointestinal bleeding than rivaroxaban or dabigatran.
Nine million fewer adults would be taking statins if clinicians followed the USPSTF guidelines.
Most patients in primary care with undiagnosed chest pain do not undergo diagnostic testing.
The researchers found heterogeneity in the association between recorded alcohol consumption and the initial presentation of 12 cardiovascular diseases.
Researchers observed a higher incidence of hypertension in patients with knee osteoarthritis compared with patients without osteoarthritis.
The updated guideline includes recent advances in diagnostic imaging and improvements in catheter-based and surgical interventions for patients with valvular heart disease.
A daily dose of atorvastatin could reduce pulmonary artery pressure among patients with COPD.
In older adults, the consequences of functional impairment include increased morbidity and mortality, and reduced ability to perform activities of daily living.
Researchers also observed no difference in 30-day mortality rates between patients in the ICU and those who received regular inpatient care in another hospital unit.
Anticoagulation with dabigatran was associated with fewer bleeding complications compared with warfarin among patients undergoing ablation for atrial fibrillation.
A longer period between P2Y12 inhibitor administration and primary percutaneous coronary intervention improves coronary reperfusion.
Same-day discharge after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes was not predictive of 30-day readmission, death, or bleeding.
Researchers find that hospitalizations and deaths among heart failure patients are highest during winter months.
Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.
NSAID use during ARI was associated with a 3.4-fold increased risk of AMI compared with 2.7-fold increased risk without NSAID use.
Electronic cigarettes cause an imbalance of cardiac autonomic tone and increased oxidative stress, which may increase cardiovascular risk.
Higher-potency statins increased hospitalization for community-acquired pneumonia compared with lower-potency statins.
The AHA found that irregular eating patterns are less ideal for maintaining body weight and cardiometabolic health.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
RASIs reduced cardiovascular events and death only when compared with placebo but not when compared with active controls.
The device has shut down due to an intermittent connection between the battery and electrical contacts.
An estimated 12.3% of Americans over the age of 21 have masked hypertension.
Researchers observed a connection between advancing age, systemic inflammation, cardiovascular disease, and caffeine.
The ACP and the AAFP has released a joint recommendation for the pharmacologic treatment of hypertension in adults aged 60 years and older.
Individuals who perform their physical activity in 1 or 2 sessions during the week can still reduce their risk of mortality.
Prescription rates for statins were dependent on age among patients with severe dyslipidemia.
Researchers examined the association between statin use and the risk of uterine fibroids and fibroid-related symptoms.
The use of a decision aid in patients at risk of acute coronary syndrome increased patient knowledge about their risk.
Depending on race, sex, and ethnicity, the right statin type may lower the risk of Alzheimer disease.
Drinking small amounts of alcohol may increase the risk of atrial fibrillation.
Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.
The prevalence of elevated blood pressure rates shifted from high-income to low- and middle-income countries.
Patients who also took either lovastatin or simvastatin had a 40% higher risk of major hemorrhage than those who took other statins.
The AHA/ACC guideline updates the 2005 recommendations on PAD management.
The reduction in thromboembolism was attenuated after accounting for competing death events.
PCSK9 inhibition produces incremental benefits on coronary disease progression in patients treated with statins.
The task force finalizes recommendations for statin therapy among adults between 40 and 75 years of age.
Ambulatory high-dose intravenous diuretic therapy could be cost saving compared with hospitalization for intravenous loop diuretic therapy.
Caffeine consumption in patients with systolic heart failure does not induce arrhythmias both at rest and during physical exercise.
One in 6 patients hospitalized for a first episode of syncope experiences a pulmonary embolism.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.
The AABB evaluated studies that examined hemoglobin thresholds for red blood cell transfusion and red blood cell storage duration.
Some individual NSAIDs may be linked to increased risk of hospital admission for heart failure.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Statin-based therapy had a smaller effect in reducing major vascular events in patients with advanced chronic kidney disease.
Researchers found that dietary changes, other medications, and surgery can also lower cardiovascular risk.
Researchers observed a lower frequency of statin recommendation with ESC guidelines compared with the AHA/ACC guidelines.
Foods fortified with folic acid are associated with a decrease in infants being born with congenital heart defects.
Patients with obstructive sleep apnea did not have reduced cardiovascular events after CPAP in addition to usual care.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
The American Heart Association has released a science advisory regarding the cardiovascular risks associated with sedentary behavior.
Current evidence is insufficient to weigh the balance of benefits and harms of screening.
Patients with type 2 diabetes with systolic blood pressure lower than 140 mm Hg have a lower risk of cardiovascular events.
The American Heart Association has published a scientific statement that outlines which medications cause or exacerbate heart failure.
At 16 months, 30.3% of patients either died or experienced worsening heart failure.
Specific patient characteristics predicted the type of therapy more likely to be prescribed.
Readmission was more common among publically insured, black patients presenting with comorbidities including hypertension and diabetes.
Reductions in disease risk were observed for an intake as high as 7.5 servings of whole grains per day.
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
The HEART pathway app provides doctors in the ED with a digital application an already proven method of assessment.
Non-vitamin K antagonist oral anticoagulants perform similarly to warfarin for patients with atrial fibrillation.
Researchers found that mortality rates dropped less than 1% between 2011 and 2014.
Incident events were most common in those within the lowest tertile of basline ALT serum.
Baseline renal function tests may predict the risk of preeclampsia and preterm birth for pregnant women with hypertension.
For patients with intracerebral hemorrhage, intensive blood pressure reduction has similar outcomes compared with standard treatment.
The FDA warns that the antidiarrheal loperamide can lead to serious cardiac events when taken in high doses.
Antiretroviral therapy in HIV-positive patients did not decrease the progression of arterial inflammation.
Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives
Compared with other estrogen doses and progestogen types, low-dose estrogen with levonorgestrel had a decreased risk of adverse events.
Women who experience migraines had a 50% greater risk for developing major CVD.
Aspirin significantly reduces the risk of a recurrent stroke 6 weeks after a transient ischemic attack or minor stroke.
Even those who are in overall poor health and medically frail could benefit from hypertension interventions.
The link is elevated in women 40 years of age or younger.
Deferred defibrillation was not associated with improved survival.
Study results showed a higher risk of CHD in women who work rotating night shifts.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
Patients with psoriasis are more likely to have an abdominal aortic aneurysm, with the likelihood increasing with more severe psoriasis.
The USPSTF concluded that a low-dose aspirin regimen can prevent cardiovascular disease and colorectal cancer in adults aged 50 to 59.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
Patients with coronary artery disease who were previously not considered candidates for CABG may benefit from the surgery.
Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.
Training the public in bystander CPR and first responder defibrillation improves outcomes for cardiac arrest that occurs outside of a hospital.
Results from a study presented at ACC in Chicago suggest that statins can be more widely used in patients considered to be intermediate risk for cardiovascular disease.
A large study found that use of SSRI medications to treat depression does not increase the risk of cardiovascular events in patients 20 to 64 years of age.
Electronic consultation between PCPs and specialists can resolve cases faster than if a patient followed up with a specialist themselves.
Women and men experience different symptoms, risks, and outcomes of myocardial infarction.
Patients who were obese and underwent bariatric surgery saw a significant reduction in heart failure-related exacerbation events.
Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Although pioglitazone decreased the risk of stroke and myocardial infarction in this population, it elevated the risk of weight gain, edema, and bone fracture.
Cardiovascular deaths have significantly decreased among people with rheumatoid arthritis.
A one-point increase in the American Heart Association's Life's Simple 7 checklist correlated to a 23% lower risk of developing heart failure.
After adult cardiac surgery, patients are less likely to be readmitted to the hospital if they receive house calls from PAs.